Russian Chemical Bulletin

, Volume 67, Issue 4, pp 624–635 | Cite as

Mechanism of action of anti-opioid peptides at pain syndrome

  • A. I. Levashova
  • M. A. Myagkova


An important goal of modern medicinal chemistry is to study the mechanisms of pain and analgesia in order to design effective analgesic drugs. Opioid analgesics are the gold standard for the treatment of severe pain; however, the use of opiates is associated with the development of side effects which are, in particular, related to the activation of the anti-opioid system. Mammalians synthesize a number of endogenous peptides, such as orphanin FGGFTGARKSARKLANQ, neuropeptide FF (FLFQPQRF-NH2), tripeptide melanostatin (MIF) PLG-NH2, as well as related compounds. These anti-opioid peptides are to one extent or another involved in homeostatic control of transmission of pain impulses. The present review includes the data published to date in domestic and foreign literature on the involvement of these peptides in such undesirable phenomena as inhibition of opioid analgesia, development of opioid tolerance and dependence, and hyperalgesia. Cell-cell and molecular ligand-receptor and receptor-receptor interactions of the opioid and anti-opioid systems are considered. These data can be useful for the design of new pharmaceuticals for pain relief. The generalization and study of these mechanisms are reflected in various approaches to treatment of pain syndromes and require analysis and further investigation.

Key words

anti-opioid system peptides orphanin neuropeptide FF MIF desensitization pain analgesic drugs 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    A. B. Danilov, Novaya Apteka [New Pharmacy], 2008, No. 9, 74 (in Russian).Google Scholar
  2. 2.
    V. G. Ovsyannikov, A. E. Boichenko, V. V. Alekseev, A. V. Kapliev, N. S. Alekseeva, I. M. Kotieva, A. E. Shumarin, Med. Vestn. Yuga Rossii [Medical Herald of the South of Russia], 2014, No. 3, 46 (in Russian).Google Scholar
  3. 3.
    F. W. Sertürner, J. Pharm., 1805, 13,234.Google Scholar
  4. 4.
    J. A. H. Lord, A. A. Waterfield, J. Hughes, H. W. Kosterlitz, Nature, 1977, 267,495.CrossRefPubMedGoogle Scholar
  5. 5.
    C. H. Li, D. Chung, Proc. Natl. Acad. Sci. USA, 1976, 73, 1145.CrossRefPubMedGoogle Scholar
  6. 6.
    A. Goldstein, W. Fischli, L. I. Lowney, M. Hunkapiller, L. Hood, Proc. Natl. Acad. Sci. USA, 1981, 78, 7219.CrossRefPubMedGoogle Scholar
  7. 7.
    Y. Chen, A. Mestek, J. Liu, L. Yu. Biochem. J., 1993, 295,625.CrossRefGoogle Scholar
  8. 8.
    A. Mansour, C. Fox, H. Akil, S. Watson, Trends Neurosci., 1995, 18,22.CrossRefPubMedGoogle Scholar
  9. 9.
    D. E. Richardson, Appl. Neurophysiol., 1982, 45,116.PubMedGoogle Scholar
  10. 10.
    J. W. Taylor, R. J. Miller, E. T. Kaiser, Mol. Pharmacol., 1982, 22,657.PubMedGoogle Scholar
  11. 11.
    B. A. Behnam, C. M. Deber, J. Biol. Chem., 1984, 259, 14935.PubMedGoogle Scholar
  12. 12.
    A. Milon, T. Miyazawa, T. Higashijima, Biochemistry, 1990, 29,65.CrossRefPubMedGoogle Scholar
  13. 13.
    H. L. Pan, Z. Z. Wu, H. Y. Zhou, S. R. Chen, H. M. Zhang, D. P. Li, Pharmacol. Ther., 2008, 117,141.CrossRefPubMedGoogle Scholar
  14. 14.
    B. Chieng, J. M. Bekkers, Br. J. Pharmacol., 2001, 133,337.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    M. R. Bruchas, C. Chavkin, J. Psychopharm., 2010, 210,137.CrossRefGoogle Scholar
  16. 16.
    A. L. Zefirov, A. M. Petrov, Sinapticheskaya vesikula i mekhanism osvobozhdeniya mediatora (ekso-endotsitoznyi vesikulyarnyi tsikl) [Synaptic Vesicle and Mechanism of Mediator Release (Exo-Endocytic Vesicular Cycle)], Art-cafe, Kazan, 2010, 356 pp. (in Russian).Google Scholar
  17. 17.
    L. Kotecki, M. Hearing, N. M. McCall, F. Marron, M. Pravetoni, D. Arora, N. C. Victoria, M. B. Munoz, Z. Xia, P. A. Slesinger, C. D. Weaver, K. Wickman, J. Neurosci., 2015, 35, 7131.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Yu. B. Lishmanov, L. N. Maslov, N. V. Solenkova, Eksper. Klin. Farmakol. [Exp. Clin. Pharmacol.], 2006, 69, No. 2, 62 (in Russian).Google Scholar
  19. 19.
    A. A. Spasov, O. Yu. Grechko, D. M. Shtareva, Eksper. Klin. Farmakol. [Exp. Clin. Pharmacol.], 2014, 77, No. 11, 27 (in Russian).Google Scholar
  20. 20.
    D. Nockemann, M. Rouault, D. Labuz, P. Hublitz, K. McKnelly, F. C Reis, C. Stein, P. A. Heppenstall, EMBO Mol. Med., 2013, 5, 1263.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    G. Berecki, L. Motin, D. J. Adams, Mol. Pharmacol., 2016, 89,187.CrossRefPubMedGoogle Scholar
  22. 22.
    G. Zamponi, K. P. M. Currie, Biochim. Biophys. Acta, 2013, 1828, 1629.CrossRefPubMedGoogle Scholar
  23. 23.
    S. Herlitze, D. E. Garcia, K. Mackie, B. Hille, T. Scheuer, W. A. Catterall, Nature, 1996, 380,258.CrossRefPubMedGoogle Scholar
  24. 24.
    O. V. Yakovleva, A. V. Yakovlev, G. F. Sitdikova, Adenil attsiklaznaya i guanilattsiklaznaya sistemy vnutrikletochnykh vtorichnykh posrednikov [Adenilate Cyclase and Guanylate Cyclase Systems of Intracellular Secondary Messengers], KSU, Kazan, 2009, 48 pp. (in Russian).Google Scholar
  25. 25.
    G. W. Zamponi, E. Bourinet, D. Nelson, J. Nargeot, T. P. Snutch, Nature, 1997, 385,442.CrossRefPubMedGoogle Scholar
  26. 26.
    N. Qin, D. Platano, R. Olcese, E. Stefani, L. Birnbaumer, Proc. Natl. Acad. Sci. USA, 1997, 94, 8866.CrossRefPubMedGoogle Scholar
  27. 27.
    K. M. Page, C. Canti´, G. J. Stephens, N. S. Berrow, A. C. Dolphin, J. Neurosci., 1998, 18, 4815.CrossRefPubMedGoogle Scholar
  28. 28.
    P. Enrico, M.A. Mura, G. Esposito, P. Serra, R. Migheli, G. DeNatale, M. S. Desole, M. Miele, E. Miele, Brain Res., 1998, 797,94.CrossRefPubMedGoogle Scholar
  29. 29.
    A. H. Mulder, A. N. M. Schoffelmeer, in Opioids, Eds A. Herz, H. Akil, E. J. Simon, Springer Verlag, Berlin, 1993, p.124.Google Scholar
  30. 30.
    M. Jalabert, R. Bourdy, J. Courtin, P. Veinante, O. J. Manzoni, M. Barrot, F. Georges, Proc. Natl. Acad. Sci. USA, 2011, 108, 16446.CrossRefPubMedGoogle Scholar
  31. 31.
    F. S. Nugent, E. C. Penick, J. A. Kauer, Nature, 2007, 446, 1086.CrossRefPubMedGoogle Scholar
  32. 32.
    R. Al-Hasani, M. R. Bruchas, Anesthesiology, 2011, 115, 1363.PubMedPubMedCentralGoogle Scholar
  33. 33.
    E. H. Chartoff, H. S. Connery, Front. Pharmacol., 2014, 5,116.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    C. M. Cahill, W. Walwyn, A. M. Taylor, A. A. Pradhan, C. J. Evans, Trends Pharmacol. Sci., 2016, 37,963.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    H. Khademi, F. Kamangar, P. Brennan, R. Malekzadeh, Arch. Iran. Med., 2016, 19,870.PubMedGoogle Scholar
  36. 36.
    L. A. Roeckel, G. M. Le Coz, C. Gavériaux-Ruff, F. Simonin, Neuroscience, 2016, 3,160.CrossRefGoogle Scholar
  37. 37.
    R. M. G. Nair, A. J. Kastin, A. V. Schally, Biochem. Biophys. Res. Commun., 1971, 43, 1376.CrossRefPubMedGoogle Scholar
  38. 38.
    A. J. Kastin, R. D. Olson, R. H. Ehrensing, M. C. Berzas, A. V. Schally, D. H. Coy, Pharmacol. Biochem. Behav., 1979, 11,721.CrossRefPubMedGoogle Scholar
  39. 39.
    M. A. Gillman, F. J. Lichtigfeld, J. R. Soc. Med., 1981, 74,943.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    A. Horvath, A. J. Kastin, J. Biol. Chem., 1989, 264, 2175.PubMedGoogle Scholar
  41. 41.
    J. Erchegyi, A. J. Kastin, J. E. Zadina, Peptides, 1992, 13,623.CrossRefPubMedGoogle Scholar
  42. 42.
    L. Hackler, A. J. Kastin, J. E. Zadina, Peptides, 1994, 15,945.CrossRefPubMedGoogle Scholar
  43. 43.
    A. Bocheva, E. Dzambazova-Maximova, Folia Med., 2004, 46,42.Google Scholar
  44. 44.
    A. Bocheva, E. Dzambazova-Maximova, Methods Find. Exp. Clin. Pharmacol., 2004, 26,673.CrossRefPubMedGoogle Scholar
  45. 45.
    W. Pan, A. J. Kastin, Peptides, 2007, 28, 2411.CrossRefPubMedGoogle Scholar
  46. 46.
    R. K. Reinscheid, H.-P. Nothacker, A. Bourson, A. Ardati, R. A. Henningsen, J. R. Bunzow, D. K. Grandy, H. Langen, F. J. Monsma, Jr., O. Civelli, Science, 1995, 270,792.CrossRefPubMedGoogle Scholar
  47. 47.
    J. C. Meunier, C. Mollereau, L. Toll, C. Suaudeau, C. Moisand, P. Alvinerie, J. L. Butour, J. C. Guillemot, P. Ferrara, B. Monsarrat, H. Mazarguil, G. Vassart, M. Parmentier, J. Costentin, Nature, 1995, 377,532.CrossRefPubMedGoogle Scholar
  48. 48.
    H.-P. Nothacker, R. K. Reinscheid, A. Ardati, R. A. Henningsen, J. Monsma, Jr., S. J. Watson, O. Civelli, Proc. Natl. Acad. Sci. USA, 1996, 93, 8677.CrossRefPubMedGoogle Scholar
  49. 49.
    H. Y. Yang, W. Fratta, E. A. Majane, E. Costa, Proc. Natl. Acad. Sci. USA, 1985, 82, 7757.CrossRefPubMedGoogle Scholar
  50. 50.
    S. J. Perry, H. E. Yi-Kung, D. Cronk, J. Bagust, R. Sharma, R. J. Walker, S. Wilson, J. F. Burke, FEBS Lett., 1997, 409,426.CrossRefPubMedGoogle Scholar
  51. 51.
    L. Moulédous, C. Mollereau, J. M. Zajac, Biofactors, 2010, 36,423.CrossRefPubMedGoogle Scholar
  52. 52.
    L. S. Guzevatykh, T. A. Voronina, S. B. Seredenin, T. G. Emel´yanova, L. A. Andreeva, L. Yu. Alfeeva, N. F. Miasoedov, Biol. Bull., 2008, 35, 50 [Izv. Akad. Nauk, Ser. Biol., 2008, 35, 61].CrossRefGoogle Scholar
  53. 53.
    J. E. Zadina, A. J. Kastin, E. F. Krieg, D. H. Coy, Pharmacol. Biochem. Behav., 1982, 17, 1193.CrossRefPubMedGoogle Scholar
  54. 54.
    J. E. Zadina, A. J. Kastin, L.-J. Ge, V. Brantl, Life Sci., 1990, 47, PL–25.CrossRefGoogle Scholar
  55. 55.
    M. G. Luciano, J. E. Zadina, A. J. Kastin, D. H. Coy, Brain Res. Bull., 1981, 7,677.CrossRefPubMedGoogle Scholar
  56. 56.
    R. Zamfirova, A. Bocheva, Y. Dobrinova, S. Todorov, Auton. Autacoid. Pharmacol., 2007, 27,93.CrossRefPubMedGoogle Scholar
  57. 57.
    J. E. Zadina, A. J. Kastin, L.-J. Ge, L. Hackler, Life Sci., 1994, 55, PL–461.CrossRefGoogle Scholar
  58. 58.
    R. H. Ehrensing, A. J. Kastin, G. F. Michell, Pharmacol. Biochem. Behav., 1984, 21,975.CrossRefPubMedGoogle Scholar
  59. 59.
    A. Dupont, F. Labrie, G. Pelletier, R. Puviani, D. H. Coy, A. V. Schally, A. J. Kastin, J. Endocrinol., 1975, 64,243.CrossRefPubMedGoogle Scholar
  60. 60.
    S. Chiu, Y. W. Wong, Y. P. Wan, P. Chiu, R. K. Mishra, Prog. Neuropsychopharmacol. Biol. Psychiatry, 1983, 7,739.CrossRefPubMedGoogle Scholar
  61. 61.
    R. S. Khan, C. Yu, A. J. Kastin, Y. He, R. H. Ehrensing, H. Hsuchou, K. P. Stone, W. Pan, Int. J. Pept., 2010, ID 537639; Scholar
  62. 62.
    J. E. Zadina, S. L. Chang, L.-J. Ge, A. J. Kastin, J. Pharmacol. Exp. Ther., 1993, 265,254.PubMedGoogle Scholar
  63. 63.
    J. E. Zadina, A. J. Kastin, Peptides, 1985, 6,965.CrossRefPubMedGoogle Scholar
  64. 64.
    J. E. Zadina, A. J. Kastin, L.-J. Ge, Neurosci. Lett., 1990, 110,143.CrossRefPubMedGoogle Scholar
  65. 65.
    I. Lengyel, F. Toth, D. Biyashev, I. Szatmari, K. Monory, C. Tomboly, G. Toth, S. Benyhe, A. Borsodi, J. Physiol. Pharmacol., 2016, 67,605.PubMedGoogle Scholar
  66. 66.
    H. Mazarguil, C. Gouarderes, J. A. M. Tafani, D. Marcus, M. Kotani, C. Mollereau, M. Roumy, J. M. Zajac, Peptides, 2001, 22, 1471.CrossRefPubMedGoogle Scholar
  67. 67.
    M. Miskolzie, G. Kotovych, Biopolymers, 2003, 69,201.CrossRefPubMedGoogle Scholar
  68. 68.
    C. Mollereau, L. Mouledous, S. Lapalu, G. Cambois, C. Moisand, J. L. Butour, J. C. Meunier, Mol. Pharmacol., 1999, 55,324.CrossRefPubMedGoogle Scholar
  69. 69.
    R. K. Reinscheid, A. Ardati, F. J. Monsma, Jr., O. Civelli, J. Biol. Chem., 1996, 271, 14163.CrossRefPubMedGoogle Scholar
  70. 70.
    M. J. Orsini, I. Nesmelova, H. C. Young, B. Hargittai, M. P. Beavers, J. Liu, P. J. Connolly, S. A. Middleton, K. H. Mayo, J. Biol. Chem., 2005, 280, 8134.CrossRefPubMedGoogle Scholar
  71. 71.
    D. G. Lambert, Nat. Rev. Drug Discov., 2008, 7,694.CrossRefPubMedGoogle Scholar
  72. 72.
    M. Allard, D. Jordan, J. M. Zajac, C. Ries, D. Martin, D. Monkounga, N. Kopp, G. Simonnet, Brain Res., 1994, 633,127.CrossRefPubMedGoogle Scholar
  73. 73.
    J. R. Bunzow, C. Saez, M. Mortrud, C. Bouvier, J. T. Williams, M. Low, D. K. Grandy, FEBS Lett., 1994, 347,284.CrossRefPubMedGoogle Scholar
  74. 74.
    L. N. Maslov, Yu. B. Lishmanov, J. Kalo, L. Ma, Eksp. Klin. Farmakol. [Exp. Clin. Pharmacol.], 2003, 66, No. 5, 59 (in Russian).Google Scholar
  75. 75.
    J. A. Bonini, K. A. Jones, N. Adham, C. Forray, R. Artymyshyn, M. M. Durkin, K. E. Smith, J. A. Tamm, L. W. Boteju, P. P. Lakhlani, R. Raddatz, W. J. Yao, K. L. Ogozalek, N. Boyle, E. V. Kouranova, Y. Quan, P. J. Vaysse, J. M. Wetzel, T. A. Branchek, C. Gerald, B. Borowsky, J. Biol. Chem., 2000, 275, 39324.CrossRefPubMedGoogle Scholar
  76. 76.
    C. Mollereau, H. Mazarguil, D. Marcus, I. Quelven, M. Kotani, V. Lannoy, Y. Dumont, R. Quirion, M. Detheux, M. Parmentier, J. M. Zajac, Eur. J. Pharmacol., 2002, 451,245.CrossRefPubMedGoogle Scholar
  77. 77.
    P. Panula, A. A. Aarnisalo, K. Wasowicz, Prog. Neurobiol., 1996, 48,461.CrossRefPubMedGoogle Scholar
  78. 78.
    M. Roumy, J. M. Zajac, Eur. J. Pharmacol., 1998, 345,1.CrossRefPubMedGoogle Scholar
  79. 79.
    Q. Liu, X. M. Guan, W. J. Martin, T. P. McDonald, M. K. Clements, Q. Jiang, Z. Zeng, M. Jacobson, D. L. Williams, Jr., H. Yu, D. Bomford, D. Figueroa, J. Mallee, R. Wang, J. Evans, R. Gould, C. P. Austin, J. Biol. Chem., 2001, 276, 36961.CrossRefPubMedGoogle Scholar
  80. 80.
    C. Gouarderes, I. Quelven, C. Mollereau, H. Mazarguil, S. Q. Rice, J. M. Zajac, Neuroscience, 2002, 115,349.CrossRefPubMedGoogle Scholar
  81. 81.
    Y. T. Lin, S. C. Kao, Y. J. Day, C. C. Chang, J. C. Chen, Eur. J Pain., 2016, 20,895.CrossRefPubMedGoogle Scholar
  82. 82.
    N. A. Elshourbagy, R. S. Ames, L. R. Fitzgerald, J. J. Foley, J. K. Chambers, P. G. Szekeres, N. A. Evans, D. B. Schmidt, P. T. Buckley, G. M. Dytko, P. R. Murdock, G. Milligan, D. A. Groarke, K. B. Tan, U. Shabon, P. Nuthulaganti, D. Y. Wang, S. Wilson, D. J. Bergsma, H. M. Sarau, J. Biol. Chem., 2000, 275, 25965.CrossRefPubMedGoogle Scholar
  83. 83.
    H.-Y. T. Yang, M. J. Iadarola, Neuroscience, 2003, 118,179.CrossRefPubMedGoogle Scholar
  84. 84.
    H.-Y. T. Yang, M. J. Iadarola, Peptides, 2006, 27,943.CrossRefPubMedGoogle Scholar
  85. 85.
    L. Kivipelto, P. Panula, J. Comp. Neurol., 1991, 307,107.CrossRefPubMedGoogle Scholar
  86. 86.
    J. Lameh, F. Bertozzi, N. Kelly, P. M. Jacobi, D. Nguyen, A. Bajpai, G. Gaubert, R. Olsson, L. R. Gardell, J. Pharmacol. Exp. Ther., 2010, 334,244.CrossRefPubMedGoogle Scholar
  87. 87.
    V. K. Kontinen, E. A. Kalso, Peptides, 1995, 16,973.CrossRefPubMedGoogle Scholar
  88. 88.
    C. Gouardères, K. Jhamandas, M. Sutak, J. M. Zajac, Br. J. Pharmacol., 1996, 117,493.CrossRefPubMedPubMedCentralGoogle Scholar
  89. 89.
    M. Xu, V. K. Kontinen, P. Panula, E. Kalso, Peptides, 1999, 20, 1071.CrossRefPubMedGoogle Scholar
  90. 90.
    Q. Fang, T. Jiang, N. Li, Z. Han, R. Wang, Protein Pept. Lett., 2011, 18,403.CrossRefPubMedGoogle Scholar
  91. 91.
    L. M. Harrison, A. J. Kastin, J. E. Zadina, Peptides, 1998, 19,749.CrossRefPubMedGoogle Scholar
  92. 92.
    H. Y. Yang, W. Fratta, E. A. Majane, E. Costa, Proc. Natl. Acad. Sci. USA, 1985, 82, 7757.CrossRefPubMedGoogle Scholar
  93. 93.
    P. Oberling, L. Stinus, M. Le Moal, G. Simonnet, Peptides, 1993, 14,919.CrossRefPubMedGoogle Scholar
  94. 94.
    E. Lingueglia, E. Deval, M. Lazdunski, Peptides, 2006, 27, 1138.CrossRefPubMedGoogle Scholar
  95. 95.
    T. W. Sherwood, C. C. Askwith, J. Biol. Chem., 2008, 283, 1818.CrossRefPubMedGoogle Scholar
  96. 96.
    D. I. Osmakov, Y. A. Andreev, S. A. Kozlov, Biochemistry (Moscow), 2014, 79, 1528.CrossRefGoogle Scholar
  97. 97.
    R. B. Rothman, Synapse, 1992, 12,129.CrossRefPubMedGoogle Scholar
  98. 98.
    G. Simonnet, C. Rivat, NeuroReport, 2003, 14,1.CrossRefPubMedGoogle Scholar
  99. 99.
    L. M. Harrison, A. J. Kastin, J. E. Zadina, JPET, 1998, 284,611.Google Scholar
  100. 100.
    K. Elhabazi, J. M. Trigo, C. Mollereau, L. Moulédous, J. M. Zajac, F. Bihel, M. Schmitt, J. J. Bourguignon, H. Meziane, B. Petit-Demoulière, F. Bockel, R. Maldonado, F. Simonin, Br. J. Pharmacol., 2012, 165,424.CrossRefPubMedPubMedCentralGoogle Scholar
  101. 101.
    D. H. Malin, J. R. Lake, M. V. Hammond, D. E. Fowler, R. B. Rogillio, S. L. Brown, J. L. Sims, B. M. Leecraft, H. Y. Yang, Peptides, 1990, 11,969.CrossRefPubMedGoogle Scholar
  102. 102.
    D. H. Malin, M. M. Henceroth, J. J. Izygon, D. M. Nghiem, W. D. Moon, A. P. Anderson, C. A. Madison, P. Goyarzu, J.-N. Ma, E. S. Burstein, Neurosci. Lett., 2015, 584,141.CrossRefPubMedGoogle Scholar
  103. 103.
    D. H. Malin, J. R. Lake, D. E. Fowler, M. V. Hammond, S. L. Brown, J. E. Leyva, P. E. Prasco, T. M. Doughert, Peptides, 1990, 11,277.CrossRefPubMedGoogle Scholar
  104. 104.
    J. R. Lake, M. V. Hammond, R. C. Shaddox, L. M. Hunsicker, H. Y. Yang, D. H. Malin, Neurosci. Lett., 1991, 132,29.CrossRefPubMedGoogle Scholar
  105. 105.
    S. Allard, S. Geoffre, P. Legendre, J. D. Vincent, G. Simonnet, Brain Res., 1989, 500,169.CrossRefPubMedGoogle Scholar
  106. 106.
    R. B. Raffa, A. Kim, K.C. Rice, B. R. Decosta, E. E. Codd, R. B. Rothman, Peptides, 1994, 15,401.CrossRefPubMedGoogle Scholar
  107. 107.
    S. Chakrabarti, P. A. Madia, A. R. Gintzler, J. Neurochem., 2016, 136, 1119.CrossRefPubMedGoogle Scholar
  108. 108.
    P. A. Madia, D. M. Navani, B. C. Yoburn, Pharmacol. Biochem. Behav., 2012, 101,155.CrossRefPubMedGoogle Scholar
  109. 109.
    S. Chakrabarti, M. Rivera, S.-Z. Yan, W.-J. Tang, A. R. Gintzler, Mol. Pharmacol. 1998, 54,655.CrossRefPubMedGoogle Scholar
  110. 110.
    S. Chakrabarti, M. Oppermann, A. R. Gintzler, Proc. Natl. Acad. Sci. USA, 2001, 98, 4209.CrossRefPubMedGoogle Scholar
  111. 111.
    V. I. Tsirkin, A. D. Nozdrachev, K. Yu. Anisimov, E. N. Sizova, T. V. Polezhaeva, S. V. Khlybova, M. A. Morozova, A. N. Trukhin, Yu. V. Korotaeva, A. A. Kunshin, Vestn. Ural. Med. Akadem. Nauk [J. Ural Med. Acad. Sci.], 2016, No. 2, 147 (in Russian).CrossRefGoogle Scholar
  112. 112.
    N. Dzimiri, Eur. J. Biochem., 2002, 269, 4713.CrossRefPubMedGoogle Scholar
  113. 113.
    P. J. Barnes, J. Clin. Invest., 2006, 116, 1210.CrossRefPubMedPubMedCentralGoogle Scholar
  114. 114.
    S. Rebeyrolles, J. M. Zajac, M. Roumy, NeuroReport, 1996, 7, 2979.CrossRefPubMedGoogle Scholar
  115. 115.
    J. T. Williams, S. L. Ingram, G. Henderson, C. Chavkin, M. Zastrow, Pharmacol. Rev., 2013, 65,223.CrossRefPubMedPubMedCentralGoogle Scholar
  116. 116.
    M. Roumy, J. M. Zajac, Brain Res., 1999, 845,208.CrossRefPubMedGoogle Scholar
  117. 117.
    F. Kersante, C. Mollereau, J. M. Zajac, M. Roumy, Peptides, 2006, 27,980.CrossRefPubMedGoogle Scholar
  118. 118.
    C. Mollereau, H. Mazarguil, J. M. Zajac, M. Roumy, Mol. Pharmacol., 2005, 67,965.CrossRefPubMedGoogle Scholar
  119. 119.
    V. Dupouy, J. M. Zajac, Regul. Pept., 1995, 59,349.CrossRefPubMedGoogle Scholar
  120. 120.
    H. Y. Yang, T. Tao, M. J. Iadarola, Neuropeptides, 2008, 42,1.CrossRefPubMedGoogle Scholar
  121. 121.
    M. M. Heinricher, S. McGaraughty, D. K. Grandy, J. Neurophysiol., 1997, 78, 3351.CrossRefPubMedGoogle Scholar
  122. 122.
    Z. Pan, N. Hirakawa, H. L. Fields, Neuron, 2000, 26,515.CrossRefPubMedGoogle Scholar
  123. 123.
    M. J. Christie, Br. J. Pharmacol., 2008, 154,384.CrossRefPubMedPubMedCentralGoogle Scholar
  124. 124.
    K. M. Raehal, C. L. Schmid, C. E. Groer, L. M. Bohn, Pharmacol. Rev., 2011, 63, 1001.CrossRefPubMedPubMedCentralGoogle Scholar
  125. 125.
    T. A. Barnes, J. McDonald, D. J. Rowbotham, T. L. Duarte, D. G. Lambert, Naunyn Schmiedebergs Arch. Pharmacol., 2007, 376,217.CrossRefPubMedGoogle Scholar
  126. 126.
    L. Moulédous, C. Froment, S. Dauvillier, O. Burlet-Schiltz, J. M. Zajac, C. Mollereau, J. Biol. Chem., 2012, 287,12736.CrossRefPubMedPubMedCentralGoogle Scholar
  127. 127.
    K. Carayon, L. Moulédous, A. Combedazou, S. Mazères, E. Haanappel, L. Salomé, C. Mollereau, J. Biol. Chem., 2014, 289, 28697.CrossRefPubMedPubMedCentralGoogle Scholar
  128. 128.
    R. M. Evans, H. You, S. Hameed, C. Altier, A. Mezghrani, E. Bourinet, G. W. Zamponi, J. Biol. Chem., 2010, 285, 1032.CrossRefPubMedGoogle Scholar
  129. 129.
    W. Fujita, I. Gomes, L. A. Devi, Br. J. Pharmacol., 2015, 172,375.CrossRefPubMedGoogle Scholar
  130. 130.
    R. M. van Rijn, J. L. Whistler, M. Waldhoer, Curr. Opin. Pharmacol., 2010, 10,73.CrossRefPubMedGoogle Scholar
  131. 131.
    M. Roumy, C. Lorenzo, S. Mazères, S. Bouchet, J. M. Zajac, C. Mollereau, J. Biol. Chem., 2007, 282, 8332.CrossRefPubMedGoogle Scholar
  132. 132.
    M. Pfeiffer, T. Koch, H. Schroder, M. Laugsch, V. Hollt, S. Schulz, J. Biol. Chem., 2002, 277, 19762.CrossRefPubMedGoogle Scholar
  133. 133.
    M. Pfeiffer, S. Kirscht, R. Stumm, T. Koch, D. Wu, M. Laugsch, H. Schroder, V. Hollt, S. Schulz, J. Biol. Chem., 2003, 278, 51630.CrossRefPubMedGoogle Scholar
  134. 134.
    J. P. Vilardaga, V. O. Nikolaev, K. Lorenz, S. Ferrandon, Z. Zhuang, M. J. Lohse, Nat. Chem. Biol., 2008, 4,126.CrossRefPubMedGoogle Scholar
  135. 135.
    S. Suzuki, L. F. Chuang, P. Yau, R. H. Doi, R. Y. Chuang, Exp. Cell. Res., 2002, 280,192.CrossRefPubMedGoogle Scholar
  136. 136.
    C. Chen, J. Li, G. Bot, I. Szabo, T. J. Rogers, L. Y. Liu-Chen, Eur. J. Pharmacol., 2004, 483,175.CrossRefPubMedGoogle Scholar
  137. 137.
    D. Massotte, Br. J. Pharmacol., 2014, 172,420.CrossRefPubMedPubMedCentralGoogle Scholar
  138. 138.
    M. Le Naour, E. Akgun, A. Yekkirala, M. M. Lunzer, M. D. Powers, A. E. Kalyuzhny, J. Med. Chem., 2013, 56, 5505.CrossRefPubMedGoogle Scholar
  139. 139.
    J. L. Scavone, R. C. Sterling, E. J. Van Bockstaele, Neuroscience, 2013, 248,637.CrossRefPubMedPubMedCentralGoogle Scholar
  140. 140.
    I. Gomes, M. A. Ayoub, W. Fujita, W. C. Jaeger, K. D. Pfleger, L. A. Devi, Annu. Rev. Pharmacol. Toxicol., 2016, 56,403.CrossRefPubMedGoogle Scholar
  141. 141.
    W. Fujita, I. Gomes, L. A. Devi, Br. J. Pharmacol., 2014, 171, 4155.CrossRefPubMedPubMedCentralGoogle Scholar
  142. 142.
    K. M. Olson, W. Lei, A. Keresztes, J. LaVigne, J. M. Streicher, Yale J. Biol. Med., 2017, 90,97.PubMedPubMedCentralGoogle Scholar
  143. 143.
    I. Jlalia, N. Lensen, G. Chaume, E. Dzhambazova, L. Astasidi, R. Hadjiolova, A. Bocheva, T. Brigaud, Eur. J. Med. Chem., 2013, 62,122.CrossRefPubMedGoogle Scholar
  144. 144.
    G. R. Tabeeva, Nevrologiya, neiropsikhiatriya, psikhosoma tika [Neuro logy, Neuropsychiatry, Psychosomatics], 2013, Nos 3, 4 (in Russian).CrossRefGoogle Scholar
  145. 145.
    M. J. Robinson, S. E. Edwards, S. Iyengar, F. Bymaster, M. Clark, W. Katon, Front. Biosci. (Landmark Ed.), 2009, 14, 5031.CrossRefGoogle Scholar
  146. 146.
    Pat. WO 2009040045; publ. 02.04.2009.
  147. 147.
    M. Findeisen, D. Rathmann, A. G. Beck-Sickinger, Pharmaceuticals, 2011, 4, 1248.CrossRefPubMedCentralGoogle Scholar
  148. 148.
    S. Gicquel, H. Mazarguil, C. Desprat, M. Allard, J. P. Devillers, G. Simonnet, J. M. Zajac, J. Med. Chem., 1994, 37, 3477.CrossRefPubMedGoogle Scholar
  149. 149.
    H. Mazarguil, C. Gouarderes, J. A. Tafani, D. Marcus, M. Kotani, C. Mollereau, M. Roumy, J. M. Zajac, Peptides, 2001, 22, 1471.CrossRefPubMedGoogle Scholar
  150. 150.
    A. Mudgal, K. Kumar, C. Mollereau, S. Pasha, Chem. Biol. Drug. Des., 2016, 87,885.CrossRefPubMedGoogle Scholar
  151. 151.
    J. V. Mankus, C. R. McCurdy, Future Med. Chem., 2012, 4, 1085.CrossRefPubMedPubMedCentralGoogle Scholar
  152. 152.
    G. J. Bennett, J. M. Chung, M. Honore, Z. E. Seltzer, Curr. Protoc. Neurosci., 2003, 9, No. 9,14.PubMedGoogle Scholar
  153. 153.
    D. Le Bars, M. Gozariu, S. W. Cadden, Pharmacol. Rev., 2001, 53,597.PubMedGoogle Scholar
  154. 154.
    B. M. Broer, M. Gurrath, H. D. Holtje, J. Comput. Aided Mol. Des., 2003, 17,739.CrossRefPubMedGoogle Scholar
  155. 155.
    N. Zaveri, F. Jiang, C. Olsen, W. Polgar, L. Toll, AAPS J., 2005, 7,345.CrossRefGoogle Scholar
  156. 156.
    F. Bihel, J. P. Humbert, S. Schneider, I. Bertin, P. Wagner, M. Schmitt, E. Laboureyras, B. Petit-Demoulière, E. Schneider, C. Mollereau, G. Simonnet, F. Simonin, J. J. Bourguignon, ACS Chem. Neurosci., 2015, 6,438.CrossRefPubMedGoogle Scholar
  157. 157.
    C. Courteix, M. A. Coudoré-Civiale, A. M. Privat, T. Pélissier, A. Eschalier, J. Fialip, Pain, 2004, 110,236.CrossRefGoogle Scholar
  158. 158.
    C. M. Cremeans, E. Gruley, D. J. Kyle, M. C. Ko, J. Pharmacol. Exp. Ther., 2012, 343,72.CrossRefPubMedPubMedCentralGoogle Scholar
  159. 159.
    T. V. Khroyan, N. T. Zaveri, W. E. Polgar, J. Orduna, C. Olsen, F. Jiang, J. Pharmacol. Exp. Ther., 2007, 320,934.CrossRefPubMedGoogle Scholar
  160. 160.
    S. Molinari, V. Camarda, A. Rizzi, G. Marzola, S. Salvadori, E. Marzola, Br. J. Pharmacol., 2013, 168,151.CrossRefPubMedGoogle Scholar
  161. 161.
    N. T. Zaveri, F. Jiang, C. Olsen, W. E. Polgar, L. Toll, Bioorg. Med. Chem. Lett., 2013, 23, 3308.CrossRefPubMedPubMedCentralGoogle Scholar
  162. 162.
    K. Linz, T. Christoph, T. M. Tzschentke, T. Koch, K. Schiene, M. Gautrois, J. Pharmacol. Exp. Ther., 2014, 349,535.CrossRefPubMedGoogle Scholar
  163. 163.
    R. Guerrini, E. Marzola, C. Trapella, M. Pela', S. Molinari, M. C. Cerlesi, D. Malfacini, A. Rizzi, S. Salvadori, G. Calo, Bioorgan. Med. Chem., 2014, 22, 3703.CrossRefGoogle Scholar
  164. 164.
    A. Rizzi, D. Malfacini, M. C. Cerlesi, C. Ruzza, E. Marzola, M. F. Bird, D. J. Rowbotham, S. Salvadori, R. Guerrini, D. G. Lambert, G. Calo, Br. J. Pharmacol., 2014, 171, 4138.CrossRefPubMedPubMedCentralGoogle Scholar
  165. 165.
    M. C. Cerlesi, H. Ding, M. F. Bird, N. Kiguchi, F. Ferrari, D. Malfacini, A. Rizzi, C. Ruzza, D. G. Lambert, M. C. Ko, G. Calo, R. Guerrini, Eur. J. Pharmacol., 2017, 794, 115.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Institute of Physiologically Active CompoundsRussian Academy of Sciences, 1 Severnyi proezdChernogolovka, Moscow Region, Russian FederationRussia

Personalised recommendations